Cboe Files for Staked Injective ETF, Expanding Crypto Investment Options
- The Chicago Board Options Exchange (Cboe) submitted a filing to list shares of a staked Injective ETF proposed by Canary Capital.
- This follows an S-1 application filed with the SEC by Canary Capital on July 17.
- If approved, it would be the third staked altcoin ETF after those for staked Solana and staked Ether.
- The SEC’s review period could take up to 240 days, delaying final decisions until March 2026.
- Currently, Injective (INJ) is trading at $15.10, down over 71% from its all-time high of $52 recorded in March.
The Cboe’s filing comes amid a supportive regulatory environment under President Trump, which aims to foster innovation in crypto investment products. This ETF could enhance liquidity for INJ and attract traditional investors seeking exposure to the Injective protocol.
If approved, this ETF may significantly impact INJ’s market presence as it seeks to recover from its current price levels.(Source)
